Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Doron Lipson(Foundation Medicine (United States)), Marzia Capelletti(Dana-Farber Cancer Institute), Roman Yelensky(Foundation Medicine (United States)), Geoff Otto(Foundation Medicine (United States)), Alex Parker(Foundation Medicine (United States)), Mirna Jarosz(Foundation Medicine (United States)), John A. Curran(Foundation Medicine (United States)), Sohail Balasubramanian(Foundation Medicine (United States)), Troy Bloom(Foundation Medicine (United States)), Kristina Brennan(Foundation Medicine (United States)), Amy Donahue(Foundation Medicine (United States)), Sean R. Downing(Foundation Medicine (United States)), Garrett M. Frampton(Foundation Medicine (United States)), Lázaro Ibrahim Romero García(Foundation Medicine (United States)), Frank Juhn(Foundation Medicine (United States)), Kathy C Mitchell(Foundation Medicine (United States)), Emily White(Foundation Medicine (United States)), Jared White(Foundation Medicine (United States)), Zac Zwirko(Foundation Medicine (United States)), Tamar Peretz(Hadassah Medical Center), Hovav Nechushtan(Hadassah Medical Center), Lior Soussan‐Gutman(Teva Pharmaceuticals (Israel)), Jhingook Kim(Samsung Medical Center), Hidefumi Sasaki(Nagoya City University), Hyeong Ryul Kim(Ulsan College), Seung-Il Park(Ulsan College), Dalia Ercan(Dana-Farber Cancer Institute), Christine E. Sheehan(Albany Medical Center Hospital), Jeffrey S. Ross(Foundation Medicine (United States)), Maureen Cronin(Foundation Medicine (United States)), Pasi A. Jänne(Dana-Farber Cancer Institute), Philip J. Stephens(Foundation Medicine (United States))
Cited by 867
Abstract
Related Papers
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
William Pao, Vincent A. Miller, Maureen F. Zakowski et al.|Proceedings of the National Academy of Sciences|2004|4.3k